SLC23A2 and melanoma: In our research, ascorbate is used to compensate for the downregulated SVCT2 in order to enhance and possibly maximize the catalytic activity of TETs in melanoma cells, thus rebuilding an epigenetic profile towards that of healthy melanocytes.